Eder JP - Search Results

1

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.

Ayash LJ, Hunt M, Antman K, Nadler L, Wheeler C, Takvorian T, Elias A, Antin JH, Greenough T, Eder JP. Ayash LJ, et al. Among authors: eder jp. J Clin Oncol. 1990 Oct;8(10):1699-706. doi: 10.1200/JCO.1990.8.10.1699. J Clin Oncol. 1990. PMID: 2213105

2

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.

Seiden MV, Elias A, Ayash L, Hunt M, Eder JP, Schnipper LE, Frei E 3rd, Antman KH. Seiden MV, et al. Among authors: eder jp. Bone Marrow Transplant. 1992 Jul;10(1):57-63. Bone Marrow Transplant. 1992. PMID: 1515880

3

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C, Eder JP, Rosowsky A, Antman K, Frei E 3rd. Ayash LJ, et al. Among authors: eder jp. J Clin Oncol. 1992 Jun;10(6):995-1000. doi: 10.1200/JCO.1992.10.6.995. J Clin Oncol. 1992. PMID: 1588381

4

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, et al. Antman K, et al. Among authors: eder jp. J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102. J Clin Oncol. 1992. PMID: 1727912 Clinical Trial.

5

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.

Eder JP, Elias AD, Ayash L, Wheeler CA, Shea TC, Schnipper LE, Frei E 3rd, Antman KH. Eder JP, et al. Cancer Chemother Pharmacol. 1991;29(1):61-5. doi: 10.1007/BF00686337. Cancer Chemother Pharmacol. 1991. PMID: 1742850

6

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Hunt M, Critchlow J, Schnipper L, Frei E 3rd, et al. Elias AD, et al. Among authors: eder jp. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S208-13. doi: 10.1007/BF01613229. J Cancer Res Clin Oncol. 1991. PMID: 1795009 Clinical Trial.

7

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al. Elias AD, et al. Among authors: eder jp. J Clin Oncol. 1991 Feb;9(2):320-7. doi: 10.1200/JCO.1991.9.2.320. J Clin Oncol. 1991. PMID: 1846407 Clinical Trial.

8

A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.

Eder JP, Wheeler CA, Teicher BA, Schnipper LE. Eder JP, et al. Cancer Res. 1991 Jan 15;51(2):510-3. Cancer Res. 1991. PMID: 1985770

9

Erythropoietin gene regulation: from the laboratory to the bedside.

Goldberg MA, Gaut CC, Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, McGarigle CJ, Bunn HF. Goldberg MA, et al. Among authors: eder jp. Contrib Nephrol. 1991;88:35-45; discussion 46-7. doi: 10.1159/000419514. Contrib Nephrol. 1991. PMID: 2040197 No abstract available.

10

High-dose ifosfamide with mesna uroprotection: a phase I study.

Elias AD, Eder JP, Shea T, Begg CB, Frei E 3rd, Antman KH. Elias AD, et al. Among authors: eder jp. J Clin Oncol. 1990 Jan;8(1):170-8. doi: 10.1200/JCO.1990.8.1.170. J Clin Oncol. 1990. PMID: 2104923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters